Artificial intelligence in pharmacovigilance: A regulatory perspective on explainability
Pharmacoepidemiol Drug Saf
.
2022 Dec;31(12):1308-1310.
doi: 10.1002/pds.5524.
Epub 2022 Sep 8.
Authors
Luis Correia Pinheiro
1
,
Xavier Kurz
1
Affiliation
1
European Medicines Agency, Amsterdam, The Netherlands.
PMID:
35959980
DOI:
10.1002/pds.5524
No abstract available
Keywords:
artificial intelligence; explainability; pharmacovigilance.
MeSH terms
Adverse Drug Reaction Reporting Systems
Artificial Intelligence
Drug-Related Side Effects and Adverse Reactions*
Humans
Pharmacovigilance*